Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: A randomized, placebo-controlled trial

Journal of Clinical Psychiatry

Volumn 76, Issue 8, 2015, Pages e1015-e1022

  Matsuoka, Yutaka ^a,b   Nishi, Daisuke ^a,b   Hamazaki, Kei ^b,c   Yonemoto, Naohiro ^b   Matsumura, Kenta ^b   Noguchi, Hiroko ^b   Hashimoto, Kenji ^b,d   Hamazaki, Tomohito ^b,c  

^a NATIONAL HOSPITAL ORGANIZATION DISASTER MEDICAL CENTER   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO;

ACCIDENTAL INJURY; ADULT; ARTICLE; CLINICIAN ADMINISTERED POSTTRAUMATIC STRESS DISORDER SCALE; CONSTIPATION; CONTROLLED STUDY; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERYTHROCYTE LEVEL; DRUG RESPONSE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INJURY SEVERITY; INTENSIVE CARE; JAPAN; LIPID COMPOSITION; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; PARALLEL DESIGN; PATIENT COMPLIANCE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SECONDARY PREVENTION; ACCIDENT; BLOOD; COMPLICATION; INJURY; MIDDLE AGED; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

ACCIDENTS; ADULT; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SECONDARY PREVENTION; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 84936853400     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.14m09260     Document Type: Article

References (54)

1. Shalev AY, Freedman S, Peri T, et al. Prospective study of posttraumatic stress disorder and depression following trauma. Am J Psychiatry. 1998;155(5):630-637. doi:10.176/ajp.15.5.630 PubMed
2. Schnyder U, Moergeli H, Klaghofer R, et al. Incidence and prediction of posttraumatic stress disorder symptoms in severely injured accident victims. Am J Psychiatry. 2001;158(4):594-599. doi:10.176/api.ajp.158.4.594 PubMed
3. O'Donnell ML, Creamer M, Pattison P, et al. Psychiatric morbidity following injury. Am J Psychiatry. 2004;161(3):507-514. doi:10.176/api.ajp.161.3.507 PubMed
4. Matsuoka Y, Nishi D, Nakajima S, et al. Incidence and prediction of psychiatric morbidity after a motor vehicle accident in Japan: the Tachikawa Cohort of Motor Vehicle Accident Study. Crit Care Med. 2008;36(1):74-80. doi:10.1097/01.CM.0291650.70816.D6 PubMed
5. Kessler RC. Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry. 2000;61(suppl 5):4-12, discussion 13-14. PubMed
6. Matsuoka Y. Clearance of fear memory from the hippocampus through neurogenesis by omega-3 fatty acids: a novel preventive strategy for posttraumatic stress disorder? Biopsychosoc Med. 2011;5(1):3. doi:10.186/1751-0759-5-3 PubMed
7. Squire LR. Memory and Brain. Oxford, UK: Oxford University Press; 1987.
8. Feng R, Rampon C, Tang YP, et al. Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron. 2001;32(5):911-926. doi:10.1016/S0896-6273(01)0523-2 PubMed
9. Ressler KJ, Mayberg HS. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci. 2007;10(9):1116-1124. doi:10.1038/n194 PubMed
10. Kitamura T, Saitoh Y, Takashima N, et al. Adult neurogenesis modulates the hippocampusdependent period of associative fear memory. Cell. 2009;139(4):814-827. doi:10.1016/j.cel.209.10.020 PubMed
11. Beltz BS, Tlusty MF, Benton JL, et al. Omega-3 fatty acids upregulate adult neurogenesis. Neurosci Lett. 2007;415(2):154-158. doi:10.1016/j.neulet.207.01.010 PubMed
12. Kawakita E, Hashimoto M, Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience. 2006;139(3):991-997. doi:10.1016/j.neuroscience.206.01.021 PubMed
13. He C, Qu X, Cui L, et al. Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc Natl Acad Sci U S A. 2009;106(27):11370-11375. doi:10.1073/pnas.0904835106 PubMed
14. Matsuoka Y, Nishi D, Yonemoto N, et al. Omega-3 fatty acids for secondary prevention of posttraumatic stress disorder after accidental injury: an open-label pilot study. J Clin Psychopharmacol. 2010;30(2):217-219. doi:10.1097/JCP.0b013e3181d4830 PubMed
15. Nishi D, Koido Y, Nakaya N, et al. Fish oil for attenuating posttraumatic stress symptoms among rescue workers after the Great East Japan Earthquake: a randomized controlled trial. Psychother Psychosom. 2012;81(5): 315-317. doi:10.159/03681 PubMed
16. Matsuoka Y, Nishi D, Yonemoto N, et al. Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial. BMC Psychiatry. 2013;13(1):8. doi:10.186/1471-24X-13-8 PubMed
17. Folstein MF, Folstein SE, McHugh PR. "Minimental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198. doi:10.1016/02-3956(75)9026-6 PubMed
18. Brunet A, Weiss DS, Metzler TJ, et al. The Peritraumatic Distress Inventory: a proposed measure of PTSD criterion A2. Am J Psychiatry. 2001;158(9):1480-1485. doi:10.176/api.ajp.158.9.1480 PubMed
19. Nishi D, Matsuoka Y, Noguchi H, et al. Reliability and validity of the Japanese version of the Peritraumatic Distress Inventory. Gen Hosp Psychiatry. 2009;31(1):75-79. doi:10.1016/j.genhospsych.208.09.02 PubMed
20. Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76-82. doi:10.102/da.1013 PubMed
21. Tsubono Y, Takamori S, Kobayashi M, et al. A data-based approach for designing a semiquantitative food frequency questionnaire for a population-based prospective study in Japan. J Epidemiol. 1996;6(1):45-53. doi:10.218/jea.6.45 PubMed
22. Tsugane S, Sasaki S, Kobayashi M, et al. Validity and reproducibility of the self-administered Food Frequency Questionnaire in the JPHC Study Cohort I: study design, conduct and participant profiles. J Epidemiol. 2003;13(suppl):S2-S12. doi:10.218/jea.13.1sup2 PubMed
23. Hamazaki T, Sawazaki S, Itomura M, et al. The effect of docosahexaenoic acid on aggression in young adults: a placebo-controlled doubleblind study. J Clin Invest. 1996;97(4):1129-1133. doi:10.172/JCI18507 PubMed
24. Sawazaki S, Hamazaki T, Yazawa K, et al. The effect of docosahexaenoic acid on plasma catecholamine concentrations and glucose tolerance during long-lasting psychological stress: a double-blind placebo-controlled study. J Nutr Sci Vitaminol (Tokyo). 1999;45(5):655-665. doi:10.317/jnsv.45.65 PubMed
25. Blake DD, Weathers FW, Nagy LM, et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995;8(1):75-90. doi:10.102/jts.249080106 PubMed
26. Asukai N, Hirohata S, Kato H, et al. Psychometric properties of the Japaneselanguage version of the Clinician-Administered PTSD Scale for DSM-IV. [in Japanese] Jpn J Trauma Stress. 2003;1(1):47-53.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington DC: American Psychiatric Association; 2000.
28. Matsuoka Y, Nishi D, Nakajima S, et al. The Tachikawa cohort of motor vehicle accident study investigating psychological distress: design, methods and cohort profiles. Soc Psychiatry Psychiatr Epidemiol. 2009;44(4):333-340. doi:10.107/s0127-08-0438-6 PubMed
29. Weiss DS, Marmar CR. The Impact of Event Scale Revised. In: Wilson JP, Keane TM, eds. Assessing Psychological Trauma and PTSD. New York, NY: The Guilford Press; 1997:399-411.
30. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33, quiz 34-57. PubMed
31. Otsubo T, Tanaka K, Koda R, et al. Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview. Psychiatry Clin Neurosci. 2005;59(5):517-526. doi:10.1/j.140-1819.205.01408.x PubMed
32. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-389. doi:10.192/bjp.134.4.382 PubMed
33. Takahashi N, Tomita K, Higuchi T, et al. The inter-rater reliability of the Japanese version of the Montgomery-Asberg Depression Rating Scale (MADRS) using a structured interview guide for MADRS (SIGMA). Hum Psychopharmacol. 2004;19(3):187-192. doi:10.102/hup.576 PubMed
34. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361-370. doi:10.1/j.160-047.1983.tb09716.x PubMed
35. Kugaya A, Akechi T, Okuyama T, et al. Screening for psychological distress in Japanese cancer patients. Jpn J Clin Oncol. 1998;28(5):333-338. doi:10.1093/jco/28.5.3 PubMed
36. Brewin CR, Andrews B, Valentine JD. Metaanalysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol. 2000;68(5):748-766. doi:10.1037/02-06X.68.5.748 PubMed
37. Ozer EJ, Best SR, Lipsey TL, et al. Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis. Psychol Bull. 2003;129(1):52-73. doi:10.1037/03-2909.129.1.52 PubMed
38. The Ministry of Health, Labour and Welfare, Japan. National Health and Nutrition Survey: 2005. http://www.mhlw.go.jp/houdou/2005/04/h0421-1b.html. Accessed February 2008.
39. Itomura M, Fujioka S, Hamazaki K, et al. Factors influencing EPA+DHA levels in red blood cells in Japan. In Vivo. 2008;22(1):131-135. PubMed
40. McNutt LA, Wu C, Xue X, et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157(10):940-943. doi:10.1093/aje/kwg074 PubMed
41. Nishi D, Matsuoka Y, Nakajima S, et al. Are patients after severe injury who drop out of a longitudinal study at high risk of mental disorder? Compr Psychiatry. 2008;49(4):393-398. doi:10.1016/j.compsych.208.02.03 PubMed
42. Enders CK. A primer on the use of modern missing-data methods in psychosomatic medicine research. Psychosom Med. 2006;68(3):427-436. doi:10.1097/01.psy.021275.75056.d8 PubMed
43. Lin PY, Mischoulon D, Freeman MP, et al. Are omega-3 fatty acids antidepressants or just mood-improving agents? the effect depends upon diagnosis, supplement preparation, and severity of depression. Mol Psychiatry. 2012;17(12):1161-1163, author reply 1163-1167. doi:10.1038/mp.2012.1 PubMed
44. Martins JG, Bentsen H, Puri BK. Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated metaanalysis. Mol Psychiatry. 2012;17(12):1144-1149, discussion 1163-1167. doi:10.1038/mp.2012.25 PubMed
45. Sublette ME, Ellis SP, Geant AL, et al. Metaanalysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry. 2011;72(12):1577-1584. doi:10.408/JCP.10m0634 PubMed
46. Su KP, Lai HC, Yang HT, et al. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial. Biol Psychiatry. 2014;76(7):559-566. doi:10.1016/j.biopsych.2014.01.08 PubMed
47. Amminger GP, Schafer MR, Papageorgiou K, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010;67(2):146-154. doi:10.101/archgenpsychiatry.209.192 PubMed
48. Matsuoka Y, Nishi D, Hamazaki K. Serum levels of polyunsaturated fatty acids and the risk of posttraumatic stress disorder. Psychother Psychosom. 2013;82(6):408-410. doi:10.159/035193 PubMed
49. Maekawa M, Takashima N, Matsumata M, et al. Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PLoS ONE. 2009;4(4):e5085. doi:10.1371/journal.pone.05085 PubMed
50. Dyall SC, Michael GJ, Michael-Titus AT. Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. J Neurosci Res. 2010;88(10):2091-2102. doi:10.102/jnr.2390 PubMed
51. Sakayori N, Kimura R, Osumi N. Impact of lipid nutrition on neural stem/progenitor cells. Stem Cells Int. 2013;2013:973508. doi:10.15/2013/973508 PubMed
52. Hamanaka S, Asukai N, Kamijo Y, et al. Acute stress disorder and posttraumatic stress disorder symptoms among patients severely injured in motor vehicle accidents in Japan. Gen Hosp Psychiatry. 2006;28(3):234-241. doi:10.1016/j.genhospsych.206.02.07 PubMed
53. Nishi D, Noguchi H, Yonemoto N, et al. Incidence and prediction of post-traumatic stress disorder at 6 months after motor vehicle accidents in Japan. Psychosomatics. 2013;54(3):263-271. PubMed
54. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12):1048-1060. doi:10.101/archpsyc